Drug Retail

Shares of Express Scripts (NASDAQ: ESRX) have jumped 5.52% to $104.56 in today's trading session. The activity in the stock coincides with news that Walgreen Co. (NYSE: WAG) is ending its new pharmacy-benefit-management business with CVS Caremark (NYSE: CVS). According to analysts, this news could...

Shares of Walgreen Co. (NYSE: WAG) are lower on the session by 1.78%, currently trading $30.29. The stock has been falling sharply for the past six weeks and is now sitting on the $30 historical support level. Options trading is favoring the put side today. The June $31 strikes has traded 2,060...

While there is still a glut of poor performing commercial real estate on the market these days, those who invest in triple-net properties are enjoying better times. Triple-net leases are long-term contracts in which the tenants take responsibility for maintenance, taxes and insurance on the...

Cusick’s Corner This was a nice move to the upside, but a key component was missing -- volume. Today’s upside move had very little volume support, probably due to lack of fund buying. This is contradictory to recent downside moves which had very strong volume, most likely due to fund...

Analysts at Citigroup reiterate their "buy" rating on CVS Caremark Corp (NYSE: CVS). The target price for CVS is set to $40. Each business segment of CVS is outperforming. According to Citigroup, “Management was very upbeat about the 2011 selling season and reiterated that net new business was...

By John Tamny of Forbes Market commentators are pointing to the dollar’s surge against other paper currencies, quiescent producer prices, looming government austerity in Europe, and “asset deflation” as signals of the monetary phenomenon that is deflation.  All four pervert deflation’s true meaning...

Analysts at Credit Suisse downgrade Walgreen Company (NYSE: WAG) from "outperform" to "neutral." WAG’s shares lost 1.11% to close at $34.81 yesterday. More Analyst Ratings here

Shares of CVS Caremark Corp. (NYSE: CVS) are trading slightly lower on the session, currently off 0.74% to $36.23. The stock is now hovering around the 50-day moving average, though options traders are betting that the company will move higher off of that support level. The January 2011 $35 call...

CVS Caremark (NYSE: CVS), today announced that Chairman, President and Chief Executive Officer Thomas M. Ryan will retire from his position as CEO at next year's Annual Meeting of Shareholders in May 2011. The BOD is appointing Larry J. Merlo, 54, as President and Chief Operating Officer, and...

Today was the day when top retailers ranging from Costco Wholesale (NASDAQ: COST) to Gap (NYSE: GPS) posted disappointing same-store sales for the month of April. The results were a clear indication that Wall Street was expecting too much of a consumer rebound. Of the 28 retailers tracked by...

A strong performance in the pharmacy sales segment saw CVS Caremark’s (NYSE: CVS) Q1 profits rise by 4.5%, despite the poor performance of nonpharmaceutical products. The year’s guidance has been raised by 3 cents per share. CVS Caremark’s management is quite confident of meeting the 13% to 16%...

An increase in pharmacy revenues caused the quarterly profits of the largest US prescription drugs provider, CVS Caremark Corp (NYSE: CVS), jump by 4.5%. From $738 million or $0.50 a share a year back, CVS’ Q1 net income has risen to $771 million or $0.55 a share. Excluding one-time items, profits...

U.S. stocks rallied Monday, helped by a number of positive economic data and reports that European leaders and the International Monetary Fund had agreed to an aid plan worth about $146 billion for Greece.  United Airlines’ plans to acquire Continental in a $3 billion all-stock deal also encouraged...

• Baker Hughes (NYSE:BHI) reported first quarter results which beat Zacks estimates by 3 cents, at 41 cents per share as revenues fell 4.8% to $2.54 billion, beating Zacks estimates of $2.45 billion • Merck (NYSE:MRK) posted earnings of 83 cents per share, eight cent better than Zacks expectations...